342 related articles for article (PubMed ID: 35351965)
1. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
[TBL] [Abstract][Full Text] [Related]
2. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation.
de Souza I; Monteiro LKS; Guedes CB; Silva MM; Andrade-Tomaz M; Contieri B; Latancia MT; Mendes D; Porchia BFMM; Lazarini M; Gomes LR; Rocha CRR
Cell Death Dis; 2022 Jul; 13(7):591. PubMed ID: 35803910
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
4. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
Shi L; Chen H; Chen K; Zhong C; Song C; Huang Y; Wang T; Chen L; Li C; Huang A; Qi S; Li H; Lu Y
Clin Cancer Res; 2023 Aug; 29(16):3172-3188. PubMed ID: 37249604
[TBL] [Abstract][Full Text] [Related]
5. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
6. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Wei Y; Duan S; Gong F; Li Q
Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells.
Wu Y; Franzmeier S; Liesche-Starnecker F; Schlegel J
Cells; 2023 Oct; 12(21):. PubMed ID: 37947601
[TBL] [Abstract][Full Text] [Related]
9. LINC01564 Promotes the TMZ Resistance of Glioma Cells by Upregulating NFE2L2 Expression to Inhibit Ferroptosis.
Luo C; Nie C; Zeng Y; Qian K; Li X; Wang X
Mol Neurobiol; 2022 Jun; 59(6):3829-3844. PubMed ID: 35420382
[TBL] [Abstract][Full Text] [Related]
10. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
12. Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Babu D; Mudiraj A; Yadav N; Y B V K C; Panigrahi M; Prakash Babu P
Cell Oncol (Dordr); 2021 Aug; 44(4):889-905. PubMed ID: 33948872
[TBL] [Abstract][Full Text] [Related]
13. ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis.
Wu Y; Kram H; Gempt J; Liesche-Starnecker F; Wu W; Schlegel J
Cells; 2022 Dec; 11(24):. PubMed ID: 36552781
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Nam Y; Koo H; Yang Y; Shin S; Zhu Z; Kim D; Cho HJ; Mu Q; Choi SW; Sa JK; Seo YJ; Kim Y; Lee K; Oh JW; Kwon YJ; Park WY; Kong DS; Seol HJ; Lee JI; Park CK; Lee HW; Yoon Y; Wang J
Genome Med; 2023 Mar; 15(1):16. PubMed ID: 36915208
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
16. Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.
Fabro F; Kers TV; Feller KJ; Beerens C; Ntafoulis I; Idbaih A; Verreault M; Connor K; Biswas A; Salvucci M; Prehn JHM; Byrne AT; O'Farrell AC; Lambrechts D; Dilcan G; Lodi F; Arijs I; Kremer A; Tching Chi Yen R; Chien MP; Lamfers MLM; Leenstra S
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958662
[TBL] [Abstract][Full Text] [Related]
17. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
[TBL] [Abstract][Full Text] [Related]
18. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
20. Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.
Subramani E; Radoul M; Najac C; Batsios G; Molloy AR; Hong D; Gillespie AM; Santos RD; Viswanath P; Costello JF; Pieper RO; Ronen SM
Cancer Res; 2020 Nov; 80(22):5098-5108. PubMed ID: 32958546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]